Xenon Pharmaceuticals Earnings
NASDAQ: XENEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Mon, Nov 2, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.17
Xenon Pharmaceuticals earnings summary
Xenon Pharmaceuticals is scheduled to report Sep/2026 earnings on Nov 2, 2026, with analysts expecting EPS of $-1.17. In its most recent report on Aug 6, 2026 (Q2 2026), XENE posted EPS of $-1.11. Revenue for the quarter was $0.
Across the last 16 reports, XENE shares moved an average of 2.9% (in either direction) in the first trading session after results, rising 5 times and falling 11 times.
Summary generated from market data by MetaCap's automated system. Methodology
XENE earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-1.11 | — | -1.6% |
| May 7, 2026 | — | $-1.17 | — | -3.6% |
| Feb 26, 2026 | — | $-1.31 | — | -3.0% |
| Nov 3, 2025 | — | $-1.15 | — | +6.6% |
| Aug 11, 2025 | — | $-1.07 | — | +1.6% |
| May 12, 2025 | — | $-0.83 | — | -1.8% |
| Feb 27, 2025 | — | $-0.83 | — | -1.4% |
| Nov 12, 2024 | — | $-0.81 | — | +3.3% |
| Aug 8, 2024 | — | $-0.75 | — | -4.5% |
| May 9, 2024 | — | $-0.62 | — | -1.8% |
| Feb 29, 2024 | — | $-0.65 | — | -1.3% |
| Nov 8, 2023 | — | $-0.73 | — | +2.1% |
| Aug 9, 2023 | — | $-0.72 | — | -3.2% |
| May 9, 2023 | — | $-0.63 | — | +2.1% |
| Mar 1, 2023 | — | $-0.59 | — | -7.6% |
| Nov 8, 2022 | — | $-0.57 | — | -0.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.